Status:
UNKNOWN
Eicosanoids in Human Heart Failure
Lead Sponsor:
University Hospital, Motol
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
Our translational project aims to evaluate the role of eicosanoids in human HF.
Detailed Description
Heart failure (HF) is the leading cause of cardiovascular hospitalizations, and with its increasing prevalence, the healthcare systems face a heart failure pandemic. Translational research findings im...
Eligibility Criteria
Inclusion
- Heart failure
Exclusion
- None
Key Trial Info
Start Date :
August 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05305170
Start Date
August 1 2021
End Date
December 31 2024
Last Update
April 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Motol
Prague, Czechia